Fecal immunochemical testing in colorectal cancer screening of average risk individuals: economic evaluation
Heitman S, Au F, Hilsden R, Manns B
Record ID 32011001216
English
Authors' recommendations:
Based on the available evidence, FIT seems to be superior to FOBT screening, particularly in the detection of polyps. More study is warranted.Compared with no screening, FIT-mid was associated with a cost per QALY of $4,350, which was robust to sensitivity analysis. If jurisdictions implement screening programs using FIT, volume-based contracts could be used to achieve lower prices for the FIT assays. To optimize FIT test performance, programs could include the testing of two to three stool samples.
Details
Project Status:
Completed
URL for project:
http://www.cadth.ca/media/pdf/M0012_FIT_Economic_Evaluation_L3_e.pdf
Year Published:
2009
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Colorectal Neoplasms
- Early Detection of Cancer
- Mass Screening
- Occult Blood
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.